3425 | Psilocybine1H-indol-4-ol, 3-[2-(dimethylamino)ethyl]-, 4-(dihydrogen phosphate), 3-(2-Dimethylaminoethyl)-1H-indol-4-ol dihydrogen phosphate, 3-[2-(Dimethylamino)ethyl]-1H-indol-4-yl phosphate, 4-Phosphoryl-N,N-dimethyltryptamine, Cy 39, Indocybin, Indol-4-ol,3-(2-dimethylamino)ethyl)-dihydrogenphosphate, o-Phosphoryl-4-hydroxy-N,N-dimethyltryptamine, Psilocine phosphate, [3-(2-Dimethylaminoethyl)-1H-indol-4-yl] dihydrogen phosphate | | Customs Act | Minister's Item 2-2 Import Approval (Drugs) | Narcotics | Prohibition of import and export | Ministry of Finance | | Minister's Item 2-2 Import Approval (Drugs) |
2886 | Psilocybine1H-indol-4-ol, 3-[2-(dimethylamino)ethyl]-, 4-(dihydrogen phosphate), 3-(2-Dimethylaminoethyl)-1H-indol-4-ol dihydrogen phosphate, 3-[2-(Dimethylamino)ethyl]-1H-indol-4-yl phosphate, 4-Phosphoryl-N,N-dimethyltryptamine, Cy 39, Indocybin, Indol-4-ol,3-(2-dimethylamino)ethyl)-dihydrogenphosphate, o-Phosphoryl-4-hydroxy-N,N-dimethyltryptamine, Psilocine phosphate, [3-(2-Dimethylaminoethyl)-1H-indol-4-yl] dihydrogen phosphate | | Narcotics and Psychotropic Control Act | Narcotics | | License required for import/export, possession, acquisition/transfer, and use | Ministry of Health, Labour and Welfare | | Narcotics and Psychotropic Control Act |
2960 | Psilocybine1H-indol-4-ol, 3-[2-(dimethylamino)ethyl]-, 4-(dihydrogen phosphate), 3-(2-Dimethylaminoethyl)-1H-indol-4-ol dihydrogen phosphate, 3-[2-(Dimethylamino)ethyl]-1H-indol-4-yl phosphate, 4-Phosphoryl-N,N-dimethyltryptamine, Cy 39, Indocybin, Indol-4-ol,3-(2-dimethylamino)ethyl)-dihydrogenphosphate, o-Phosphoryl-4-hydroxy-N,N-dimethyltryptamine, Psilocine phosphate, [3-(2-Dimethylaminoethyl)-1H-indol-4-yl] dihydrogen phosphate | | Narcotics and Psychotropic Control Act | Plants for narcotic raw materials | | License or a registration as research and development facility required in the case of manufacture and use of stimulants for fundamental research or research and development | Ministry of Health, Labour and Welfare | | Narcotics and Psychotropic Control Act |